Surge2surgery is an immunological model capable of predicting postoperative infections.
Business Model:
Revenue: $0
Employees: 0-0
Address:
City: Paris
State: Ile-de-France
Zip:
Country: France
Surge2surgery is an immunological model capable of predicting postoperative infections. The company combines a single-cell assessment of the immune system before surgery with clinical data using a proprietary machine-learning algorithm. By analyzing the millions of immune cells in a small amount of blood, the platform can mimic surgical trauma in a test tube before surgery.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 9/2022 | Pre Seed Round | 4 | $2.6M |
Nicolas Godin HCVC Gregoire Delpit Boutique Venture Partners Nicolas Godin HCVC Gregoire Delpit Boutique Venture Partners |
2/2022 | Non Equity Assistance | 1 | - |
AGORANOV AGORANOV |
2/2022 | Non Equity Assistance | 1 | - |
AGORANOV AGORANOV |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|